Sartorius expects profitable growth in 2024

Double-digit annual sales revenue growth projected through to 2028

31-Jan-2024 - Sartorius expects a return to profitable growth in 2024 and a dynamic business development for the five-year period through to 2028. In 2023, soft demand, which lasted longer than expected post-pandemic, led to a temporary decline in sales revenue and earnings across the entire life science ...

Sanofi joins digital health focused innovation program Startup Creasphere

24-Jan-2019 - Startup Creasphere, the first digital health innovation hub in Europe, has today announced a partnership with the consumer healthcare business unit of Sanofi. Sanofi will partner with Startup Creasphere and other companies in creating the ultimate hub of digital health innovation in Europe, where ...

Stora Enso announces startups selected for its second Accelerator Programme

23-Jan-2019 - Stora Enso has chosen six startups to join its second Accelerator Programme, a joint startup initiative organised by Stora Enso, Aalto University Developing Entrepreneurship (Aalto ENT) and Vertical Accelerator.The Accelerator programme provides an exceptional opportunity for disruptive startups ...

Stora Enso awarded as Finland’s most startup-friendly company

10-Oct-2018 - The renewable materials company Stora Enso has been awarded as the most start-up-friendly company in Finland in 2018. The prize was awarded by Tribe Tampere at the AlihankintaHEAT event in Tampere. Stora Enso runs two startup programmes which have produced good results in business ...

Enzymicals extend its capacity in Business Development

04-Sep-2018 - Dr. Rainer Wardenga is one of the co-founders of Enzymicals and support the Business Development of the company beginning September. Dr. Wardenga is biotechnologist and until the beginning of his parentalleave, he was responsible for the development of the company with focus on research and ...

Concept Life Sciences achieves record profits

Strengthens senior team

20-Dec-2017 - Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced a successful financial year, ending 2017 with revenues in excess of $65m/£49m. The Company also welcomes Dr Andrew Scott as Head of Bioassay Development and Screening, and ...

Recipharm signs manufacturing agreement and acquires facility in Spain

21-Sep-2017 - Recipharm AB announces that it has entered into collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose products. Recipharm will also acquire a manufacturing facility currently employing approximately 200 people located in ...

PerkinElmer announces third quarter results

GAAP Revenue of $548 million versus $563 million in the comparable prior period

08-Nov-2016 - PerkinElmer, Inc. reported financial results for the third quarter ended October 2, 2016. The Company reported GAAP earnings per share from continuing operations of $0.52, as compared to $0.48 in the third quarter of 2015. GAAP revenue in the third quarter of 2016 was $548.1 million, as compared ...

Bayer: strong growth in Life Sciences

01-Aug-2013 - The Bayer Group achieved strong growth in its Life Sciences businesses in the second quarter of 2013. "At HealthCare, the launches of new pharmaceutical products are progressing considerably better than expected. And CropScience maintained its gratifying business development in a positive market ...

Algeta appoints Dr. Donald Coppen as Business Development Director

05-May-2011 - Algeta ASA announced that it has appointed Donald Coppen as Business Development Director.Dr. Coppen will join Chief Business Officer Roger Harrison in driving Algeta's business development strategy aimed at advancing its Thorium payload technology for creating novel targeted cancer therapies, ...